Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma. Xu A, Chu X, Zhang S, Zheng J, et al. BMC Cancer 2022;22:872.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu A, Chu X, Zhang S, Zheng J, et al. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma. BMC Cancer 2022;22:872.
PMID: 35945526